Abstract
Cystic fibrosis (CF) is a life-shortening genetic disease that results in the overproduction of thick, sticky mucus throughout the body. Symptoms are progressive, and management requires a burdensome daily medical regimen. Individuals with CF also require hospital admissions lasting 10–14 days to treat illness exacerbations. Given that individuals with CF and their caregivers are more likely to develop symptoms of anxiety and depression, inpatient CL providers are in a prime position to deliver psychological treatment to children and families while also interfacing with and educating the medical team (both inpatient and outpatient). Common referral concerns can include, but are not limited to, anxiety and depression, adherence promotion, coping with disease progression, and promoting function in the hospital environment. Working effectively with bedside staff and attending medical providers are a key focus of treatment for individuals with CF and their families. Aspects of interventions should be modified as appropriate for this population, particularly keeping in mind infection control guidelines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barker, D. H., & Quittner, A. L. (2016). Parental depression and pancreatic enzymes adherence in children with cystic fibrosis. Pediatrics, 137(2), 1–9. https://doi.org/10.1542/peds.2015-2296
Blackwell, L. S., & Quittner, A. L. (2015). Daily pain in adolescents with CF: Effects on adherence, psychological symptoms, and health-related quality of life. Pediatric Pulmonology, 50(3), 244–251. https://doi.org/10.1002/ppul.23091
Boat, T. F., Filigno, S., & Amin, R. S. (2017). Wellness for families of children with chronic health disorders. Journal of the American Medical Association Pediatrics, 171(9), 825–826. https://doi.org/10.1001/jamapediatrics.2017.1682
Borschuk, A. P., Everhart, R. S., Eakin, M. N., Rand-Giovannetti, D., Borrelli, B., & Riekert, K. A. (2016). Disease disclosure in individuals with cystic fibrosis: Association with psychosocial and health outcomes. Journal of Cystic Fibrosis, 15(5), 696–702. https://doi.org/10.1016/j.jcf.2016.02.011
Comeau, A. M., Accurso, F. J., White, T. B., Campbell, P. W., 3rd, Hoffman, G., Parad, R. B., … Cystic Fibrosis, F. (2007). Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics, 119(2), e495–e518. https://doi.org/10.1542/peds.2006-1993
Cystic Fibrosis Foundation. (2018a, December 2). Bronchodilators. Retrieved from https://www.cff.org/Life-With-CF/Treatments-and-Therapies/Medications/Bronchodilators/
Cystic Fibrosis Foundation. (2018b, December 2). What is cystic fibrosis. Retrieved from https://www.cff.org/What-is-CF/About-Cystic-Fibrosis/
Ernst, M. M., Johnson, M. C., & Stark, L. J. (2010). Developmental and psychosocial issues in cystic fibrosis. Child and Adolescent Psychiatric Clinics of North America, 19(2), 263–283. https://doi.org/10.1016/j.chc.2010.01.004
Filigno, S., Strong, S., Hente, E., Elam, M., Mara, C., & Boat, T. (2017). Promoting school success for students with cystic fibrosis: A novel empirically-based program. Pediatric Pulmonology, 52, S484–S484.
Filigno, S., Strong, S., Hente, E., Murphy, C., Elam, M., Mara, C., … Boat, T. (2018). We have a lot to learn: School needs and school absences for student with cystic fibrosis. Pediatric Pulmonology, 53, 407–407.
Friedman, D., Pinsky, H., Quittner, A., Salathe, M., Smith, B., & Georgiopoulos, A. (2018). Development of a CF-specific CBT intervention to prevent depression and anxiety in adults with CF. Pediatric Pulmonology, 53, 409–409.
Gravelle, A. M., Paone, M., Davidson, A. G., & Chilvers, M. A. (2015). Evaluation of a multidimensional cystic fibrosis transition program: A quality improvement initiative. Journal of Pediatric Nursing, 30(1), 236–243. https://doi.org/10.1016/j.pedn.2014.06.011
Grossoehme, D. H., Filigno, S. S., & Bishop, M. (2014). Parent routines for managing cystic fibrosis in children. Journal of Clinical Psychology in Medical Settings, 21(2), 125–135. https://doi.org/10.1007/s10880-014-9396-1
Jamieson, N., Fitzgerald, D., Singh-Grewal, D., Hanson, C. S., Craig, J. C., & Tong, A. (2014). Children’s experiences of cystic fibrosis: A systematic review of qualitative studies. Pediatrics, 133(6), e1683–e1697. https://doi.org/10.1542/peds.2014-0009
Kazak, A. E., Brier, M., Alderfer, M. A., Reilly, A., Fooks Parker, S., Rogerwick, S., … Barakat, L. P. (2012). Screening for psychosocial risk in pediatric cancer. Pediatric Blood & Cancer, 59(5), 822–827. https://doi.org/10.1002/pbc.24166
Li, S. S., Tumin, D., Krone, K. A., Boyer, D., Kirkby, S. E., Mansour, H. M., & Hayes, D., Jr. (2018). Risks associated with lung transplantation in cystic fibrosis patients. Expert Review of Respiratory Medicine, 12(11), 893–904. https://doi.org/10.1080/17476348.2018.1522254
Madan, A. S., Alpern, A. N., & Quittner, A. L. (2014). Transition from pediatric to adult cystic fibrosis care: A developmental framework. European Respiratory Society Monograph, 64, 272–285.
Masson, A., Kirszenbaum, M., & Sermet-Gaudelus, I. (2017). Pain is an underestimated symptom in cystic fibrosis. Current Opinion in Pulmonary Medicine, 23(6), 570–573. https://doi.org/10.1097/MCP.0000000000000427
Modi, A. C., Lim, C. S., Yu, N., Geller, D., Wagner, M. H., & Quittner, A. L. (2006). A multi-method assessment of treatment adherence for children with cystic fibrosis. Journal of Cystic Fibrosis, 5(3), 177–185. https://doi.org/10.1016/j.jcf.2006.03.002
Modi, A. C., Pai, A. L., Hommel, K. A., Hood, K. K., Cortina, S., Hilliard, M. E., … Drotar, D. (2012). Pediatric self-management: A framework for research, practice, and policy. Pediatrics, 129(2), e473–e485. https://doi.org/10.1542/peds.2011-1635
O’Hayer, C., Aikens, R., O’Loughlin, C., Bennett, D., Lee, H., Hendry, M., & Stephen, M. (2018). ACT with CF: Promising conclusions of a telehealth pilot study of acceptance and commitment therapy for anxiety and depression. Pediatric Pulmonology, 53, 408–S2. Abstract 677.
Powers, S. W., Stark, L. J., Chamberlin, L. A., Filigno, S. S., Sullivan, S. M., Lemanek, K. L., … Clancy, J. P. (2015). Behavioral and nutritional treatment for preschool-aged children with cystic fibrosis: A randomized clinical trial. Journal of the American Medical Association Pediatrics, 169(5), e150636. https://doi.org/10.1001/jamapediatrics.2015.0636
Quittner, A. L., Goldbeck, L., Abbott, J., Duff, A., Lambrecht, P., Sole, A., … Barker, D. (2014). Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: Results of the international depression epidemiological study across nine countries. Thorax, 69(12), 1090–1097. https://doi.org/10.1136/thoraxjnl-2014-205983
Saiman, L., Siegel, J. D., LiPuma, J. J., Brown, R. F., Bryson, E. A., Chambers, M. J., … Society for Healthcare Epidemiology of America. (2014). Infection prevention and control guideline for cystic fibrosis: 2013 update. Infection Control and Hospital Epidemiology, 35(Suppl 1), S1–S67. https://doi.org/10.1086/676882
Sanders, D. B., Zhang, Z., Farrell, P. M., Lai, H. J., & Wisconsin, C. F. N. S. G. (2018). Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis. Journal of Cystic Fibrosis, 17(4), 528–535. https://doi.org/10.1016/j.jcf.2018.01.006
Smith, B. A., Modi, A. C., Quittner, A. L., & Wood, B. L. (2010). Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatric Pulmonology, 45(8), 756–763. https://doi.org/10.1002/ppul.21238
Stark, L. J., Quittner, A. L., Powers, S. W., Opipari-Arrigan, L., Bean, J. A., Duggan, C., & Stallings, V. A. (2009). Randomized clinical trial of behavioral intervention and nutrition education to improve caloric intake and weight in children with cystic fibrosis. Archives of Pediatrics and Adolescent Medicine, 163(10), 915–921. https://doi.org/10.1001/archpediatrics.2009.165
Talwalkar, J. S., Koff, J. L., Lee, H. B., Britto, C. J., Mulenos, A. M., & Georgiopoulos, A. M. (2017). Cystic fibrosis transmembrane regulator modulators: Implications for the management of depression and anxiety in cystic fibrosis. Psychosomatics, 58(4), 343–354. https://doi.org/10.1016/j.psym.2017.04.001
Tluczek, A., Orland, K. M., & Cavanagh, L. (2011). Psychosocial consequences of false-positive newborn screens for cystic fibrosis. Qualitative Health Research, 21(2), 174–186. https://doi.org/10.1177/1049732310382919
VanDevanter, D. R., Kahle, J. S., O’Sullivan, A. K., Sikirica, S., & Hodgkins, P. S. (2016). Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment. Journal of Cystic Fibrosis, 15(2), 147–157. https://doi.org/10.1016/j.jcf.2015.09.008
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Borschuk, A.P., Filigno, S.S. (2020). Cystic Fibrosis. In: Carter, B.D., Kullgren, K.A. (eds) Clinical Handbook of Psychological Consultation in Pediatric Medical Settings. Issues in Clinical Child Psychology. Springer, Cham. https://doi.org/10.1007/978-3-030-35598-2_25
Download citation
DOI: https://doi.org/10.1007/978-3-030-35598-2_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35597-5
Online ISBN: 978-3-030-35598-2
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)